Loading clinical trials...
Loading clinical trials...
A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating The Efficacy and Safety of Multiple Treatment Combinations in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (Morpheus-Head and Neck Cancer)
Conditions
Interventions
Atezolizumab
Tiragolumab
+2 more
Locations
6
United States
City of Hope
Duarte, California, United States
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Hadassah University Hospital - Ein Kerem
Jerusaelm, Israel
Severance Hospital - Yonsei Cancer Center
Seoul, South Korea
Asan Medical Center
Seoul, South Korea
Start Date
April 12, 2023
Primary Completion Date
August 15, 2024
Completion Date
August 15, 2024
Last Updated
September 15, 2025
NCT06868433
NCT05815927
NCT06736379
NCT05747625
NCT05783622
NCT05329532
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions